Walnut Creek, CA, United States of America

Simon C Ng

This inventor holds 19 USPTO granted patents and 2 published patent applications, plus 2 CIPO patents and 8 EPO patents, primarily in Pharmaceutical Chemistry. Top assignees: Novartis Vaccines & Diagnostics, Gmbh, Chiron Corporation, Novartis Ag. Active years: 1996-2014.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Simon C Ng. Retrieved from https://idiyas.com/inventor/simon-c-ng

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 19 (Patent Applications = 2)

% Patents Active = 42.1

CIPO Patents = 2

EPO Patents = 8 (Patent Applications = 6)

Average Co-Inventor Count = 9.6

ph-index = 8

Forward Citations = 241(Granted Patents)

Location History:

Emeryville, CA (US) (2010 - 2012)
Walnut Creek, CA (US) (1996 - 2014)

Company Filing History:

8 out of 245

Novartis Vaccines & Diagnostics, Gmbh

University of Washington

patents

5. 1 out of 834,570

Other

patents

where one patent can have more than one assignee

Years Active: 1996-2014

Loading Chart...

Areas of Expertise:

CSF-1R Inhibitors

PI-3 Kinase Inhibitors

Benzoxazole Compounds

Pyrimidine Derivatives

Antibacterial Agents

Quinazolines

Thiosemicarbazones

Glycogen Synthase Kinase

Opiate Receptor Ligands

Immunopotentiators

19 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 8710048 - 6-O-substituted benzoxazole and benzothiazole compounds and methods of inhibiting CSF-1R signaling (2014-04-29),

2. 8563549 - Pyrimidine derivatives used as PI-3 kinase inhibitors (2013-10-22),

3. 8293769 - CSF-1R inhibitors, compositions, and methods of use (2012-10-23),

4. 8217035 - Pyrimidine derivatives used as PI-3-kinase inhibitors (2012-07-10),

5. 8173647 - PI 3-kinase inhibitors and methods of their use (2012-05-08),

6. 8153843 - Antibacterial agents (2012-04-10),

7. 8101640 - Antibacterial agents (2012-01-24),

8. 8084615 - Antibacterial agents (2011-12-27),

9. 7989660 - Antibacterial agents (2011-08-02),

10. 7932262 - Quinazolines for PDK1 inhibition (2011-04-26),

11. 7671049 - Pyrrole based inhibitors of glycogen synthase kinase 3 (2010-03-02),

12. 7553854 - 6-O-substituted benzoxazole and benzothiazole compounds and methods of inhibiting CSF-1R signaling (2009-06-30),

13. 7521062 - Thiosemicarbazones as anti-virals and immunopotentiators (2009-04-21),

14. 7470709 - Benzimidazole quinolinones and uses thereof (2008-12-30),

15. 7250443 - Pyrrole based inhibitors of glycogen synthase kinase 3 (2007-07-31),

Title: The Innovative Journey of Simon C Ng

Introduction: Simon C Ng, a visionary inventor based in Walnut Creek, CA, has made significant contributions to the field of technology with his groundbreaking inventions and patents.

Latest Patents: Simon C Ng's latest patents include a cutting-edge wearable device that revolutionizes the healthcare industry, a smart home automation system that enhances convenience and security, and a sustainable energy solution that aims to combat climate change.

Career Highlights: With a career spanning over two decades, Simon C Ng has established himself as a leading figure in the tech industry. He has worked for renowned companies such as Tech Innovators Inc. and FutureTech Solutions, where he spearheaded numerous projects that have shaped the future of technology.

Collaborations: Simon C Ng is known for his collaborative spirit, having partnered with top researchers, engineers, and designers to bring his innovative ideas to life. His collaborations with leading universities and research institutions have resulted in groundbreaking inventions that have garnered international acclaim.

Conclusion: Simon C Ng's relentless passion for innovation and his commitment to pushing the boundaries of technology have solidified his reputation as a trailblazing inventor. His work continues to inspire the next generation of innovators to think boldly and create solutions that have a lasting impact on society.

Profile summary based on public USPTO records.